---
layout: minimal-medicine
title: Lazabemide
---

# Lazabemide
### Generic Name
Lazabemide

### Usage
Lazabemide was a medication under investigation for the treatment of Parkinson's disease and related parkinsonism.  Its primary intended use was to alleviate symptoms associated with this neurodegenerative disorder by inhibiting the enzyme monoamine oxidase type B (MAO-B).  However, its development was halted due to safety concerns.

### Dosage
Because lazabemide did not proceed to market approval, definitive dosage recommendations for adults and children are not available.  Information regarding various forms (tablet, syrup, injection, etc.) and administration guidelines is unavailable.  Any information found elsewhere should be treated with extreme caution as it is likely based on pre-clinical or early clinical trial data that never reached full regulatory validation.

### Side Effects
While the full spectrum of side effects associated with lazabemide is not fully documented due to its discontinuation, the most serious side effect identified was *severe hepatotoxicity* (liver damage).  This finding was the primary reason for the termination of its development.  Other potential side effects are unknown or undocumented in readily available, reliable sources.

### How it Works
Lazabemide functioned as a selective, reversible inhibitor of monoamine oxidase B (MAO-B). MAO-B is an enzyme that breaks down dopamine, a neurotransmitter crucial for motor control. By inhibiting MAO-B, lazabemide aimed to increase the levels of dopamine in the brain, thereby potentially alleviating the motor symptoms of Parkinson's disease.  The reversible nature of the inhibition means that the effect was temporary and the enzyme's function could be restored once the drug was eliminated from the body.

### Precautions
Due to the observed severe hepatotoxicity, the most crucial precaution regarding lazabemide is to avoid its use altogether.  As it never reached the market, comprehensive information on drug interactions, contraindications, and specific warnings for vulnerable populations (pregnant women, children, the elderly) is limited and unreliable.  Any information found should be considered outdated and potentially inaccurate.

### FAQs

* **Q: Is lazabemide still available?**  A: No, lazabemide's development was discontinued due to safety concerns, and it is not currently available for medical use.

* **Q: What were the reasons for lazabemide's discontinuation?** A: Primarily, the discovery of significant hepatotoxicity (liver damage) in clinical trials led to the termination of its development and prevented it from reaching the market.

* **Q: Where can I find more information about lazabemide?** A:  Information regarding lazabemide is scarce due to its failed development.  While some pre-clinical or early clinical trial data might exist in scientific databases or archives, it should be interpreted cautiously and with the understanding that the drug was never deemed safe for widespread use.  Consulting a medical professional is crucial if you have further questions about Parkinson's treatment options.
